Hfa suspension formulations containing an anticholinergic

Details Hfa suspension formulations containing an anticholinergic Hfa suspension formulations containing an anticholinergic

A - Human Necessities

61

K

A61K 9/72 (2006.01) A61K 31/46 (2006.01)

Patent

CA 2479640

The invention relates to propellant formulations containing suspensions of a crystalline anhydrate of (1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)-7-[(hydroxydi-2- thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9- azoniatricyclo[3.3.1.02,4]nonane bromide.

L'invention concerne des suspensions d'un monohydrate cristallin de bromure de (1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)-7-[(hydroxydi-2-thiénylacétyl)oxy]-9,9-diméthyl-3-oxa-9-azoniatricyclo[3.3.1.0?2,4¿]nonane, qui contiennent des formulations de gaz propulseur.

Affiliated with

Also associated with

Rating

Hfa suspension formulations containing an anticholinergic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hfa suspension formulations containing an anticholinergic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hfa suspension formulations containing an anticholinergic will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1900993